Refine by
Locations
- Europe
- Albania
- Andorra
- Austria
- Belarus
- Belgium
- Bosnia & Herzegovina
- Bulgaria
- Croatia
- Cyprus
- Czech Republic
- Denmark
- Estonia
- Faroe Islands
- Finland
- France
- Germany
- Greece
- Hungary
- Iceland
- Ireland
- Italy
- Kosovo
- Latvia
- Liechtenstein
- Lithuania
- Luxembourg
- Macedonia
- Malta
- Moldova
- Monaco
- Montenegro
- Netherlands
- Northern Ireland
- Norway
- Poland
- Portugal
- Romania
- San Marino
- Serbia
- Slovakia
- Slovenia
- Spain
- Sweden
- Switzerland
- Turkey
- Ukraine
- United Kingdom
- Vatican City
Drug Development Program Services In Europe
4 services found
Manufactured by:Creative Biolabs based inShirley, NEW YORK (USA)
We understand the critical importance of project management in ensuring the success of the drug development programs of our clients. ...
by:Oncimmune Holdings PLC based inNottingham, UNITED KINGDOM
Viewing cancer through the immune lens (immuno-oncology) has led to the most promising advancements in cancer treatment in recent history, nonetheless the full potential of the approach is as yet ...
by:Almac Group based inCraigavon, UNITED KINGDOM
Pharmacodynamic (PD) biomarkers are extremely important in early drug development trials and can be used to measure the level of response to an administered drug, whether it is biologically active & can help to determine target engagement and mechanism of action (MOA). PD Biomarkers assist investigators to understand if the drug is having the intended pharmacologic effect and be used to guide ...
by:Almac Group based inCraigavon, UNITED KINGDOM
Almac Diagnostic Services can also help Biopharma clients validate reliable Pharmacodynamic (PD) Biomarker assays that can help provide invaluable guidance within their drug development programmes. Almac also has extensive experience in the discovery of clinically applicable biomarkers, through our own range of Almac proprietary assays (DDIR, Prostate Dx, ColDx, Angio, and EMT) and through ...